Identification of potential histone deacetylase inhibitory biflavonoids from Garcinia kola (Guttiferae) using in silico protein-ligand interaction
Abstract Overactivity of histone deacetylases (HDACs) is the underlying cause of some cancers, thus, inhibiting their overactivities is a rational treatment option. However, endeavors to employ current anti-HDACs agents in cancer treatment have yielded limited success. Consequently, there is need to explore anti-HDACs natural products, especially from plants sources, because of the intimate relationship plant products and drug discovery have enjoyed over the centuries. To identify possible HDACs inhibitors, Garcinia kola (Guttiferae) seed-derived compounds were screened in silico for HDAC-inhibitory tendencies because of their reported anticancer potentials. Fifteen G. kola-derived compounds and givinostat were docked with five selected HDACs using AutodockVina, while the binding interactions of the compounds with high binding affinities for the five HDACs were viewed with Discovery Studio Visualizer BIOVIA, 2016. Results indicated that four of the compounds studied, including amentoflavone, Garcinia biflavonoid 1, Garcinia biflavonoid 2 and kolaflavanone have higher binding propensity for all the five HDACs relative to givinostat, the standard HDAC inhibitor. This study indicated that inhibition of HDAC might be another key mechanism accountable for the bioactivities of G. kola and its intrinsic compounds. The results from this study implied that the compounds could be further investigated as drugable HDAC inhibitors with potential pharmacological applications in the treatment of cancers..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
Physical sciences reviews - 8(2021), 9 vom: 03. Mai, Seite 2127-2141 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Adewole, Kayode E. [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Anmerkungen: |
© 2021 Walter de Gruyter GmbH, Berlin/Boston |
|---|
| doi: |
10.1515/psr-2020-0099 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
GRUY009225285 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | GRUY009225285 | ||
| 003 | DE-627 | ||
| 005 | 20230929121628.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230929s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1515/psr-2020-0099 |2 doi | |
| 035 | |a (DE-627)GRUY009225285 | ||
| 035 | |a (DE-B1597)psr-2020-0099-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 530 |q VZ |
| 082 | 0 | 4 | |a 530 |q VZ |
| 100 | 1 | |a Adewole, Kayode E. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Identification of potential histone deacetylase inhibitory biflavonoids from Garcinia kola (Guttiferae) using in silico protein-ligand interaction |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2021 Walter de Gruyter GmbH, Berlin/Boston | ||
| 520 | |a Abstract Overactivity of histone deacetylases (HDACs) is the underlying cause of some cancers, thus, inhibiting their overactivities is a rational treatment option. However, endeavors to employ current anti-HDACs agents in cancer treatment have yielded limited success. Consequently, there is need to explore anti-HDACs natural products, especially from plants sources, because of the intimate relationship plant products and drug discovery have enjoyed over the centuries. To identify possible HDACs inhibitors, Garcinia kola (Guttiferae) seed-derived compounds were screened in silico for HDAC-inhibitory tendencies because of their reported anticancer potentials. Fifteen G. kola-derived compounds and givinostat were docked with five selected HDACs using AutodockVina, while the binding interactions of the compounds with high binding affinities for the five HDACs were viewed with Discovery Studio Visualizer BIOVIA, 2016. Results indicated that four of the compounds studied, including amentoflavone, Garcinia biflavonoid 1, Garcinia biflavonoid 2 and kolaflavanone have higher binding propensity for all the five HDACs relative to givinostat, the standard HDAC inhibitor. This study indicated that inhibition of HDAC might be another key mechanism accountable for the bioactivities of G. kola and its intrinsic compounds. The results from this study implied that the compounds could be further investigated as drugable HDAC inhibitors with potential pharmacological applications in the treatment of cancers. | ||
| 700 | 1 | |a Ishola, Ahmed A. |4 aut | |
| 700 | 1 | |a Omolaso, Blessing O. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Physical sciences reviews |d De Gruyter, 2016 |g 8(2021), 9 vom: 03. Mai, Seite 2127-2141 |h Online-Ressource |w (DE-627)GRUY000074934 |w (DE-600)2864634-4 |w (DE-576)475776364 |x 2365-659X |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2021 |g number:9 |g day:03 |g month:05 |g pages:2127-2141 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1515/psr-2020-0099 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_GRUY | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2021 |e 9 |b 03 |c 05 |h 2127-2141 | ||